Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that it will present ...

New Evrysdi five-year data from the SUNFISH study showed continued stabilisation of motor function in a broad population of ind ...

New Haven officially has room for one last smoke shop — which will have to obtain a municipal license, alongside all of the city’s 212 existing ...

Scholar Rock , a late-stage biopharmaceutical company focused on advancing innovative treatments for neuromuscular diseases, cardiometabolic disorders, and other serious diseases where protein growth ...

Neurocrine Biosciences, Inc.  today presented new data from the long-term, open-label KINECT® 4 study demonstrating remission of tardive dyskinesia among the majority of patients treated with ...

A NEW law that would force the HSE to ­provide care for kids needing ... outside the therapeutic window when their treatments are approved. Earlier this month, the Seanad heard how at least ...

A new program aimed at making downtown Gainesville a safe and welcoming place for residents and visitors has been ongoing for nearly four months. The Gainesville Downtown Ambassador Program provides ...

From Monday, the regulator will start enforcing the Online Safety Act’s illegal content ... The bill first came into law in October 2023, around 18 months ago, as the new laws were consulted ...

Under the bill, if a person on pretrial release tampers with an electronic monitoring device, his or her pretrial release ...

Trump gave green light to Netanyahu for strikes that Hamas says killed over 400 - Israeli officials say Trump approved ...

Tectonic Therapeutic. TX45 Phase 1b trial interim analysis demonstrated meaningful improvements in both left ventricular function and pulmonary hemodynamics in patients with Group ...

City Council meeting went past midnight due to a controversial discussion. Karin K. Jensen reports, "Fifty public speakers ...